Defense Health Innovation
Accelerating the Transition of Dual-Use Technologies
Where market-ready medical innovation meets the defense mission.
Working with us means:
Curated sourcing
We identify market-ready companies advancing field treatment, warfighter resilience, and return-to-duty solutions.
Real-world validation
Technologies are de-risked through validation with leading health systems before they reach the mission.
Government readiness
The companies we bring you arrive prepared for defense partnership — procurement-aware, compliance-ready, and aligned to mission fit.
One point of entry
A single front door to a national network of medtech companies, investors, research institutions, and industry partners.
The network behind the front door:
Founders bringing commercial innovation to the mission
Venture and strategic investors backing dual-use technologies
Leading health systems and research institutions serving as validation partners
Primes seeking vetted teaming partners
By the Numbers
- 150 active portfolio companies
- $150M in follow-on funding
- 60+ years commercializing technology
Inside the Pipeline
Our portfolio is a curated pipeline of market-ready medical technologies spanning:
Infectious disease detection and bio-surveillance
Battlefield trauma care
Combat casualty rehabilitation
Battlefield diagnostics
Human performance optimization
Critical care and brain injury
Advanced therapeutics and regenerative medicine
A snapshot of the companies advancing this work:
Federal Funding Support
By leveraging our government relationships, providing comprehensive proposal development, and deploying sophisticated award management, the Science Center streamlines the process for startups in accessing federal funding.
Wendy Nickel speaking with Heath Naquin